Broadcom
AVGO
Salesforce
CRM
Micron Technology
MU
4
Qualcomm
QCOM
5
Oracle
ORCL
US Stock MarketDetailed Quotes
FEMY Femasys
- 1.240
- 0.0000.00%
Trading Apr 24 11:52 ET
33.67MMarket Cap-1.46P/E (TTM)
1.290High1.240Low31.69KVolume1.240Open1.240Pre Close39.93KTurnover0.13%Turnover RatioLossP/E (Static)27.15MShares1.80052wk High14.59P/B29.55MFloat Cap0.86052wk Low--Dividend TTM23.83MShs Float13.750Historical High--Div YieldTTM4.03%Amplitude0.248Historical Low1.259Avg Price1Lot Size
Femasys Stock Forum
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
67
12
1
$Femasys (FEMY.US)$
Femasys Secures Game-Changing Partnership: FemaSeed Now Available at 11 Leading Fertility Centers
Femasys Secures Game-Changing Partnership: FemaSeed Now Available at 11 Leading Fertility Centers
$Femasys (FEMY.US)$ Reuters· 2 mins ago
Femasys Announces Partnership With CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer Femaseed in Its 11 Locations
Femasys Announces Partnership With CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer Femaseed in Its 11 Locations
2
$Femasys (FEMY.US)$
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations
Wednesday, 19th March at 9:20 am
ATLANTA, March 19, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, announces a partnership with CNY Fert...
Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations
Wednesday, 19th March at 9:20 am
ATLANTA, March 19, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, announces a partnership with CNY Fert...
3
$Femasys (FEMY.US)$ Benzinga· 2 mins ago
Femasys Announces Distribution Partnership For FmBloc In Spain, Comercial Medico Quirurigca to Expand Portfolio To Include FemBloc
Femasys Announces Distribution Partnership For FmBloc In Spain, Comercial Medico Quirurigca to Expand Portfolio To Include FemBloc
1
2
$Femasys (FEMY.US)$
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
Thursday, 13th March at 8:30 am
ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, anno...
Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach
Thursday, 13th March at 8:30 am
ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, anno...
1
$Femasys (FEMY.US)$
Could This Non-Surgical Birth Control Method Replace Traditional Sterilization? Clinical Trials Say Yes
Could This Non-Surgical Birth Control Method Replace Traditional Sterilization? Clinical Trials Say Yes
$Femasys (FEMY.US)$
Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials
Tuesday, 25th February at 9:20 am
--Positive data from prospective, multi-center trials confirmed compelling effectiveness and five-year safety with high satisfaction from both patients and practitioners--
ATLANTA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unme...
Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials
Tuesday, 25th February at 9:20 am
--Positive data from prospective, multi-center trials confirmed compelling effectiveness and five-year safety with high satisfaction from both patients and practitioners--
ATLANTA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unme...
$Femasys (FEMY.US)$
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
Tuesday, 11th February at 9:00 am
ATLANTA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible in-office therapeutic and diagnostic products, announces the receipt of the Medicines & Healthcare products R...
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
Tuesday, 11th February at 9:00 am
ATLANTA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible in-office therapeutic and diagnostic products, announces the receipt of the Medicines & Healthcare products R...
1
$Femasys (FEMY.US)$ Reuters· 1 min ago
Femasys -Israeli Regulatory Approvals for Femaseed for Female Infertility Treatment and Two Diagnostic Devices
Femasys -Israeli Regulatory Approvals for Femaseed for Female Infertility Treatment and Two Diagnostic Devices
No comment yet
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
ASteffie :
Hutao’s Discharge :
Hutao’s Discharge Hutao’s Discharge : there is still hope pray
keene86 : Jag bro.. how come in quantum section , qmco wasn't included.. just curious..![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
wammerjammer : Appreciate the info. Im new to trading and trying to figure all this out. Ill look into these companies
View more comments...